Back to search

National and Kapodistrian University of Athens

Μελέτη του μηχανισμού συμβολής του ογκοκατασταλτικού γονιδίου ATM στην ογκογένεση στο στόμα

Abstract

dc:description

Introduction: The oral squamous cell carcinoma (OSCC) is the most common carcinoma (90%) in the oral cavity. It is the sixth most common malignancy and a major cause of morbidity and mortality by cancer worldwide. Despite the advances in treatment, including surgery, chemotherapy and radiotherapy, there has not been any important improvement in the prognosis over the last four decades. The most important causative factors are tobacco exposure and alcohol consumption. Oral carcinogenesis is a multi-step procedure in which genetic events lead to disruption of normal regulatory pathways that control basic cellular functions. These genetic events include chromosomal disturbances, activation of oncogenes and inactivation of tumor suppressor genes, as well as DNA methylation. Therefore, the understanding of the molecular mechanisms involved in initiation and progression of oral cancer will help in the improvement of its prognosis and the development of new forms of treatment. The “ataxia telangiectasia mutated” gene, ATM, is a tumor suppressor gene which is responsible for the disease ataxia telangiectasia. This gene codes for a protein kinase, which acts as a tumor suppressor protein by triggering appropriate cellular response to genome damage resulting from chemical carcinogen exposure or ionizing radiation. When ATM kinase is inactive, cells become prone to a flow of oncogenetic events eventually leading to cancer. Purpose: The purpose of the present thesis is the detection of the most common known mutation 7636del9 as well as the investigation of the methylation status of ATM promoter in genetic material from OSCC patients and healthy subjects without malignancy. This gene was selected due to the major role it plays in cell cycle arrest after DNA damage, DNA repair and oncogenesis, in general. Materials and Methods: 67 unrelated OSCC patients and 57 healthy blood donors (controls who represent the general population) were studied, of equivalent age, ethnicity, and gender. The molecular detection of 7636del9 mutation in 124 DNA samples was effected through a combination of PCR. digestion with the restriction enzyme Xba I and gel electrophoresis. The detection of the methylation status of ATM promoter included bisulphate modification of 100 DNA samples (50 OSCC patients and 50 healthy controls) and amplification of the modified samples by methylation-specifìc PCR (MSP) using two pairs of primers, one complementary to the unmethylated DNA sequence (U) and one complementary to the methylated DNA sequence (M). Results: The 7636del9 deletion was not detected in any sample from the 124 DNA samples examined. All OSCC patients as well as the healthy subjects were homozygous for the normal allele. In regard to the methylation status of ATM promoter, statistically significant differences were observed between the methylation status of patients and controls. In the total group of patients, the frequency of the methylated allele (76%), as well as the frequencies of heterozygotes (16%) and homozygotes (68%) for the methylated allele were found increased compared to the homozygotes for the unmethylated allele (OR 28.31, 95% CI 5.04-158.93, P<0.001). Similarly, the frequency of heterozygotes was significantly higher compared to the frequency of homozygotes for the unmethylated allele (OR 5.72, 95% CI 0.77-42.21, P<0.001). Similar results were obtained during the comparison of the distribution of alleles and genotypes between the various subcategories of patients (cancer stage, family history of cancer, tobacco abuse and alcohol consumption) and the control group (P<0.001). Conclusions: The most common 7636del9 mutation was not associated with increased risk for oral cancer. Interestingly, the findings of the present study indicated that ATM promoter is a target for aberrant hypermethylation in oral cancer, based to the fact that the ATM promoter was found hyper methylated in a high percentage of oral cancer cases. ATM reduced function through genetic silencing is an attractive candidate mechanism which contributes to oral cancer and possibly, other types of cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spyridonidou, Sofia
  • Σπυριδωνίδου, Σοφία

Subjects

dc:subject × 22

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29321

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spyridonidou, Sofia; Σπυριδωνίδου, Σοφία. Μελέτη του μηχανισμού συμβολής του ογκοκατασταλτικού γονιδίου ATM στην ογκογένεση στο στόμα. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/29321